FDA Deputy Commissioner Anna K. Abram acknowledged,
CBD has been shown to be beneficial in experimental models of several neurological disorders, including those of seizure and epilepsy.
That means the FDA officially disagrees with the Drug Enforcement Administration (DEA), which late last year tried to make CBD a Schedule I controlled substance. Schedule I drugs are, by definition, those with “no currently accepted medical use in treatment in the United States.”
and
If you have pertinent information on CBD, or experience with it, you’re being encouraged to comment on this federal website. The deadline for public comment (was)September 13. No input will be considered after that date.
check out more info: link to fda-admits-cbd-beneficial/
No comments:
Post a Comment